Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$7.9 - $10.19 $1.92 Million - $2.47 Million
-242,565 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$8.38 - $10.18 $2.03 Million - $2.47 Million
242,565 New
242,565 $2.36 Million
Q1 2021

May 06, 2021

SELL
$10.34 - $12.81 $6.89 Million - $8.54 Million
-666,361 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$8.61 - $11.04 $5.74 Million - $7.36 Million
666,361 New
666,361 $6.43 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Edgestream Partners, L.P. Portfolio

Follow Edgestream Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.